FDA Import Refusal 799-3956508-9/11/1 — UCB Pharma S.A.
The FDA refused shipment 799-3956508-9/11/1 from UCB Pharma S.A. (Belgium) on Nov 4, 2019. The refused product falls under Drugs and Biologics — LEVETIRACETAM (ANTI-CONVULSANT). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Nov 4, 2019
- Country
- Belgium
- Product Category
- Drugs and Biologics
- Product Code
- 61MCA42 LEVETIRACETAM (ANTI-CONVULSANT)
- Charges
- 75